Are Options Traders Betting on a Big Move in Fresenius Medical Stock?

10.09.25 15:00 Uhr

Werte in diesem Artikel
Aktien

46,95 EUR 0,07 EUR 0,15%

Indizes

PKT PKT

2.003,2 PKT -6,0 PKT -0,30%

2.082,8 PKT -3,2 PKT -0,16%

23.639,4 PKT -35,1 PKT -0,15%

8.856,3 PKT -13,2 PKT -0,15%

1.893,9 PKT -5,9 PKT -0,31%

2.975,3 PKT 0,8 PKT 0,03%

2.143,9 PKT 0,6 PKT 0,03%

195,9 PKT -0,4 PKT -0,21%

576,7 PKT -0,2 PKT -0,04%

12.436,4 PKT -24,3 PKT -0,19%

23.639,0 PKT 0,0 PKT 0,00%

23.649,4 PKT -44,9 PKT -0,19%

9.136,9 PKT -19,9 PKT -0,22%

23.652,6 PKT -38,8 PKT -0,16%

Investors in Fresenius Medical Care AG FMS need to pay close attention to the stock based on moves in the options market lately. That is because the Oct 17, 2025 $12.50 Call had some of the highest implied volatility of all equity options today.What is Implied Volatility?Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell-off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.What do the Analysts Think?Clearly, options traders are pricing in a big move for Fresenius Medical shares, but what is the fundamental picture for the company? Currently, Fresenius Medical is a Zacks Rank #3 (Hold) in the Medical - Instruments industry that ranks in the Top 37% of our Zacks Industry Rank. Over the last 60 days, no analysts have increased their earnings estimates for the current quarter, while one analyst has revised the estimate downward. The net effect has taken our Zacks Consensus Estimate for the current quarter from earnings of 61 cents per share to 59 cents in that period.Given the way analysts feel about Fresenius Medical right now, this huge implied volatility could mean there’s a trade developing. Oftentimes, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected.Looking to Trade Options?Check out the simple yet high-powered approach that Zacks Executive VP Kevin Matras has used to close recent double and triple-digit winners. In addition to impressive profit potential, these trades can actually reduce your risk.Click to see the trades now >>Free Report: Profiting from the 2nd Wave of AI ExplosionThe next phase of the AI explosion is poised to create significant wealth for investors, especially those who get in early. It will add literally trillion of dollars to the economy and revolutionize nearly every part of our lives.Investors who bought shares like Nvidia at the right time have had a shot at huge gains.But the rocket ride in the "first wave" of AI stocks may soon come to an end. The sharp upward trajectory of these stocks will begin to level off, leaving exponential growth to a new wave of cutting-edge companies.Zacks' AI Boom 2.0: The Second Wave report reveals 4 under-the-radar companies that may soon be shining stars of AI’s next leap forward.Access AI Boom 2.0 now, absolutely free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Fresenius Medical Care AG & Co. KGaA (FMS): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Fresenius

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Fresenius

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Fresenius SE & Co. KGaA (St.)

Wer­bung

Analysen zu Fresenius SE & Co. KGaA (St.)

DatumRatingAnalyst
16.09.2025Fresenius SECo BuyJefferies & Company Inc.
15.09.2025Fresenius SECo BuyJefferies & Company Inc.
12.09.2025Fresenius SECo OverweightJP Morgan Chase & Co.
02.09.2025Fresenius SECo BuyUBS AG
25.08.2025Fresenius SECo KaufenDZ BANK
DatumRatingAnalyst
16.09.2025Fresenius SECo BuyJefferies & Company Inc.
15.09.2025Fresenius SECo BuyJefferies & Company Inc.
12.09.2025Fresenius SECo OverweightJP Morgan Chase & Co.
02.09.2025Fresenius SECo BuyUBS AG
25.08.2025Fresenius SECo KaufenDZ BANK
DatumRatingAnalyst
13.05.2025Fresenius SECo NeutralGoldman Sachs Group Inc.
07.04.2025Fresenius SECo Market-PerformBernstein Research
26.02.2025Fresenius SECo NeutralGoldman Sachs Group Inc.
04.02.2025Fresenius SECo NeutralGoldman Sachs Group Inc.
08.11.2024Fresenius SECo NeutralGoldman Sachs Group Inc.
DatumRatingAnalyst
02.11.2021Fresenius SECo UnderperformJefferies & Company Inc.
30.07.2021Fresenius SECo UnderperformJefferies & Company Inc.
23.07.2021Fresenius SECo UnderperformJefferies & Company Inc.
17.03.2021Fresenius SECo UnderperformJefferies & Company Inc.
23.02.2021Fresenius SECo UnderperformJefferies & Company Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Fresenius SE & Co. KGaA (St.) nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen